Skip to main content

Wellington Management — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

278
Companies
$59.2B
Total invested
$270.5M
Avg. check
59
Industries
Biotechnology 10Health Care 7Software 7Medical 5Therapeutics 5Artificial Intelligence (AI) 5+53 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 73–96 of 278
Generation Bio
March 2023

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Biotechnology · Cambridge$76.0M Post-IPO Equity
Quince
March 2026

Quince is an e-commerce company that offers apparel, accessories, home goods, and personal care products through an online platform.

Apparel · San Francisco$500.0M Series E
Freeline
March 2022

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Biopharma · Stevenage$26.1M Post-IPO Equity
Anchorage Digital
February 2026

Anchorage Digital is a regulated crypto platform that provides institutions with integrated financial services and infrastructure solutions.

Blockchain · San Francisco$100.0M Secondary Market
Forerunner
February 2026

Forerunner is an AI-powered geospatial platform that assists governments in updating their operations and enhancing community resilience.

Artificial Intelligence (AI) · San Francisco$26.3M Series B
BetterUp
February 2024

BetterUp provides AI and human coaching to improve leadership, management, and employee performance across organizations.

Artificial Intelligence (AI) · San Francisco$215K Venture - Series Unknown
Chroma Medicine
February 2023

Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.

Biotechnology · Cambridge$135.0M Series B
Somatus
February 2022

Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.

Health Care · Mclean$325.0M Series E
Synthego
February 2022

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Artificial Intelligence (AI) · Redwood City$200.0M Series E
Aligos Therapeutics
February 2025

Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

Biotechnology · San Francisco$105.0M Post-IPO Equity
Lendbuzz
February 2026

Lendbuzz is a car financing platform that helps consumers with thin U.S. credit history obtain financing for their car purchase.

Artificial Intelligence (AI) · Boston$246.0M Debt Financing
BEGiN
February 2026

BEGiN is an education technology company that creates learning products to bring children quality education.

Android · New YorkVenture - Series Unknown
Galecto
February 2026

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Biotechnology · Copenhagen$275.0M Post-IPO Equity
Tubulis
October 2025

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Biotechnology · Munich$400.6M Series C
Vanta
July 2025

Vanta is a trust management platform that automates compliance and risk management.

Artificial Intelligence (AI) · San Francisco$150.0M Series D
Avalyn Pharma
July 2025

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Biopharma · Seattle$100.0M Series D
AssetWatch
April 2025

AssetWatch is a deployable, remote, end-to-end condition monitoring solution providing predictive insight to enable proactive maintenance.

Big Data · Westerville$75.0M Series C
Maza
April 2025

Maza is a mobile app that offers financial products and digital banking services.

Banking · Los Angeles$10.0M Venture - Series Unknown
Atsena Therapeutics
April 2025

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

Biotechnology · Durham$150.0M Series C
Lumafield
March 2025

Lumafield develops industrial computed tomography (CT) solutions for non-destructive testing and inspection for engineers.

Hardware · Cambridge$75.0M Series C
PHND
February 2025

PHND is a subscription-free cloud gaming platform for Smart TVs.

Business Development · Stamford$10.0M Seed
Helicore Biopharma
January 2025

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

Biopharma · San Mateo$65.0M Series A
Orennia
January 2025

Orennia is a technology company focused on the renewable power sector.

Analytics · CalgarySeries C
Trace Machina
August 2024

Trace Machina is a company that specializes in the development and maintenance of simulation infrastructure.

IT Infrastructure · Palo Alto$4.7M Seed

Where Wellington Management invests

Biotechnology10
Health Care7
Software7
Medical5
Therapeutics5
Artificial Intelligence (AI)5

About Wellington Management's portfolio

How many companies has Wellington Management invested in?▸

Wellington Management has invested in 278 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Wellington Management invest in?▸

Wellington Management's top investment sectors include Biotechnology, Health Care, Software, Medical, Therapeutics. The firm invests across 59 different industry categories.

What is Wellington Management's largest investment?▸

Among tracked funding rounds, Quince received $500.0M in a Series E round. Wellington Management's total known invested capital is $59.2B.

What is the average investment size for Wellington Management?▸

Wellington Management's average investment size is $270.5M across its portfolio of 278 companies.

What are Wellington Management's most recent investments?▸

Recent Wellington Management portfolio additions include Generation Bio, Quince, Freeline, Anchorage Digital, Forerunner. These companies were founded in 2020 or later.

Reach the founders behind these 278 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →